MYOZ3 and cancer: Further validation in four independent cohorts (Fig. 9B) showed that KEAP1, SRI, MFAP1, MFAP2, INCENP, and KIF21B were consistently upregulated in cancer tissues, while MYOZ3, DST, and TIAM1 were consistently downregulated.